-+ 0.00%
-+ 0.00%
-+ 0.00%

MediPharm Labs swings to Q2 FY26 profit; revenue rises 11% to $10 million vs Q1 FY26

PUBT·08/13/2026 11:30:56
Listen to the news
MediPharm Labs swings to Q2 FY26 profit; revenue rises 11% to $10 million vs Q1 FY26
  • MediPharm Labs posted positive net income in Q2 2026, reversing a net loss of $3.8 million a year earlier.
  • Adjusted EBITDA (non-IFRS) turned to a profit of $894,000, the strongest quarterly level since 2019.
  • Revenue climbed 11% from Q1 2026 to $10 million as international medical sales rose 26% to $5.8 million.
  • Operating expenses fell 44% from Q2 2025 to $4 million, reflecting restructuring actions completed in Q1 2026.
  • Interim CEO Greg Hunter cited improved profitability and diversified revenue streams despite reimbursement and regulatory headwinds in key markets.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediPharm Labs Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608130730PRIMZONEFULLFEED9809468) on August 13, 2026, and is solely responsible for the information contained therein.